A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Conditions: Overweight; ObesityInterventions: Drug: pramlintide acetate; Drug: sibutramine; Drug: phentermine; Drug: placeboSponsor: AstraZenecaCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adipex | Eating Disorders & Weight Management | Meridia | Obesity | Phentermine | Research | Study